IPF PHARMACEUTICALS GMBH
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 22, 2010 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 49 Total Citation Count
- Nov 08, 2000 Earliest Filing
- 10 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7655629 Peptides and their use for the treatment of HIV infectionsExpiredDec 19, 03Feb 02, 10[A61K, C12Q, A61M]
2009/0149,391 Novel antimicrobial bolisin peptidesAbandonedOct 22, 08Jun 11, 09[A61K, C12P, A61P, C07K]
2009/0124,541 Method for the recovery and application of novel human defensins as biologically active proteins for the treatment of infections and other diseasesAbandonedApr 27, 07May 14, 09[A61K, A61P, C07K]
7232796 Medicament containing a tissue inhibitor of metalloproteinases-2 (TIMP-2) as an osteoanabolically active substanceExpiredApr 04, 01Jun 19, 07[A61K]
2007/0123,465 Oligomeric peptides and their use for the treatment of hiv infectionsAbandonedJun 17, 05May 31, 07[A61K, C07K]
2006/0100,145 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseasesAbandonedOct 24, 03May 11, 06[A61K, C40B, C07K]
2005/0142,101 Method of inhibiting the emigration of cells from the intravascular compartment into tissuesAbandonedFeb 08, 05Jun 30, 05[A61K]
2004/0116,652 Method for producing and using novel human defensins as biologically active proteins for treating infections and other diseasesAbandonedJan 13, 03Jun 17, 04[A61K, C07K]
2003/0186,889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interactionAbandonedSep 23, 02Oct 02, 03[A61K, G01N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.